Front Immunol 15 1456897

Corrigendum: Myelomodulatory treatments augment the therapeutic benefit of oncolytic
viroimmunotherapy in murine models of malignant peripheral nerve sheath tumors.

Paudel SN, Hutzen BJ, Miller KE, Garfinkle EAR, Chen CY, Wang PY, Glaspell AM, Currier MA, Ringwalt EM, Boon L, Mardis ER, Cairo MS, Ratner N, Dodd RD, Cassady KA, Cripe TP

[This corrects the article DOI: 10.3389/fimmu.2024.1384623.].